The table below is a review of notable updates that occurred in December 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

One hormone that could serve this function is somatostatin ... such as excess growth hormones in acromegaly and neuroendocrine tumors. First, the researchers assessed how well Consomatin G1 bound to ...

apart from one subtype of growth-hormone-secreting adenomas, hormone receptor alterations do not seem to be common events that can be implicated in the etiology and pathogenesis of the majority of ...

Molecular imaging, including somatostatin receptor scintigraphy but more so ... might control clinical symptoms and hormone release in patients resistant to standard somatostatin analog therapy.

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others ...

Acromegaly is due to hypersecretion of growth hormone and insulin-like growth ... Medical treatment of the disease is usually with somatostatin analogs. An open, prospective, single-center study ...